Recurrent major depressive disorder in childhood and adolescence in treatment with Sertraline and Agomelatine

Downloads

Published

2011-09-30

How to Cite

Ruiz-Lázaro, P. M., Gómez, C., Sanz, P., Velilla, J. M., & Lobo, A. (2011). Recurrent major depressive disorder in childhood and adolescence in treatment with Sertraline and Agomelatine. Revista De Psiquiatría Infanto-Juvenil, 28(3), 59–63. Retrieved from https://aepnya.eu/index.php/revistaaepnya/article/view/195

Issue

Vol. 28 No. 3 (2011)

Section

Case reports

Authors

  • P M Ruiz-Lázaro Universidad de Zaragoza. Instituto Aragonés de Ciencias de la Salud. I+CS. Psiquiatría Infanto-Juvenil Hospital Clínico Universitario de Zaragoza
  • C Gómez Universidad de Zaragoza. Instituto Aragonés de Ciencias de la Salud. I+CS. Psiquiatría Infanto-Juvenil Hospital Clínico Universitario de Zaragoza
  • P Sanz Universidad de Zaragoza. Instituto Aragonés de Ciencias de la Salud. I+CS. Psiquiatría Infanto-Juvenil Hospital Clínico Universitario de Zaragoza
  • J M Velilla Universidad de Zaragoza. Instituto Aragonés de Ciencias de la Salud. I+CS. Psiquiatría Infanto-Juvenil Hospital Clínico Universitario de Zaragoza
  • A Lobo Universidad de Zaragoza. Instituto Aragonés de Ciencias de la Salud. I+CS. Psiquiatría Infanto-Juvenil Hospital Clínico Universitario de Zaragoza

Keywords:

Depression, childhood, adolescence, sertraline, agomelatine

Abstract

It is now accepted that depression can also affect children and adolescents. Major depressive disorder (MDD) is a prevalent, familial recurrent illness that interferes significantly with the child’s normal development and is associated with increased risk for suicidal behaviors and psychiatric and psychosocial morbidity. Although most children and adolescents recover from the first depressive episode, 70% will experience one or more depressive recurrences. Recurrent depression represents a major target of suicide prevention. The priority is to treat first recurrent depression properly. We report the case of a female adolescent suffering recurrent depression in childhood and adolescence in maintenance antidepressant pharmacotherapy off-label with sertraline and agomelatine with full remission, recovery in 12 month follow-up assessment.

Downloads

Download data is not yet available.

References

1. Ruiz-Lázaro PM. Trastornos depresivos en la infancia y adolescencia. Rev Psiquiatr Infanto-Juv 2001; 4: 32-38.

2. Grupo de Trabajo de la GPC sobre la Depresión mayor en la infancia y la Adolescencia. Guía de Práctica Clínica sobre la Depresión mayor en la Infancia y la Adolescencia. Avalia-t.Ministerio de Ciencia e Innovación, 2009.

3. Essau CA, Chang WC. Epidemiology, comorbidity, and course of adolescent depression. In: Essaeu CA, ed. Treatments for Adolescent Depresión. Theory and Practice, New York: Oxford University Press, 2009. pp.3-25.

4. Birmaher B, Arbelaez C, Brent D. Course and outcome of child and adolescent major depressive disorder. Child Adolesc Psychiatr Clin N Am. 2002 ;11:619-37.

5. Dunn V, Goodyer IM. Longitudinal investigation into childhood- and adolescence-onset depression: psychiatric outcome in early adulthood. Br J Psychiatry. 2006; 188: 216-22.

6. Sakolsky DJ, Birmaher B. Pharmacotherapy. In: Essaeu CA, ed. Treatments for Adolescent Depresión. Theory and Practice, New York: Oxford University Press, 2009. pp. 241-260.

7. Stahl SM. Stahl’s Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. 3rd ed. New York: Cambridge University Press.